| 产品名称 |
Recombinant Human Vitronectin |
| 英文名称 |
Vitronectin |
| 纯度 |
Greater than 95% as determined by reducing SDS-PAGE |
| 内毒素 |
<0.01 EU/µg as determined by LAL test. |
| 蛋白构建 |
Recombinant Human Vitronectin is produced by our E.coli expression system and the target gene encoding Val62-Leu478 is expressed. |
| Accession |
AAH05046.1 |
| 表达宿主 |
E.coli |
| 种属 |
Human |
| 预测分子量 |
47.6 KDa |
| 制剂 |
Supplied as a 20mM PB, 10%Trehalose, 0.02%Tween80, pH 7.8. |
| 运输方式 |
The product is shipped on dry ice/polar packs.Upon receipt, store it immediately at the temperature listed below. |
| 稳定性&储存 |
Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening.Please minimize freeze-thaw cycles. |
| 复溶 |
0 |
| 分子别名 |
| Vitronectin; VTN; VN; V75; Serum-spreading factor |
| 背景介绍 |
| Vitronectin is a multifunctional glycoprotein present in blood and in the extracellular matrix. It binds glycosaminoglycans, collagen, plasminogen and the urokinase-receptor, and also stabilizes the inhibitory conformation of plasminogen activation inhibitor-1. Vitronectin may play an important role in wound healing and in tumorprogression. Vitronectin deposition has been detected in areas of brosis and necrosis in a variety of diseases, including membranous nephropathy, arteriosclerosis and degenerative central nervous system disorders. |
注意事项
本司产品仅用于科研，不用于临床诊断和治疗
